6 Despite the biological plausibility that the use of ACE inhibitors increases susceptibility to COVID-19 and severity of the illness, 7 we observed a mild trend increase in the use of lisinopril, which is often recommended for cardiovascular disease treatment but not for the treatment of COVID-19.
← all excerpts
Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020-July 2020.
1
—
—